The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Adiponectin Replenishment Ameliorates Obesity-Related Hypertension
Abstract
Patients with obesity are susceptible to hypertension. We have reported that the plasma adiponectin levels are decreased in obesity and that adiponectin has many defensive properties against obesity-related diseases, such as type 2 diabetes and coronary artery disease. The aim of this study was to determine the relationship between adiponectin and hypertension in mice. We measured blood pressure and heart rate directly by a catheter in the carotid artery and indirectly by automatic sphygmomanometer at the tail artery. Obese KKAy mice had significantly lower plasma adiponectin levels and higher systolic blood pressure than control C57BL/6J mice at 21 weeks of age. Adenovirus-delivered adiponectin significantly decreased blood pressure in KKAy mice. The direct role of adiponectin on blood pressure regulation under insulin resistance–free state was investigated in adiponectin-knockout (KO) mice. Adiponectin KO mice developed hypertension when maintained on a high-salt diet (8% NaCl) without insulin resistance. The hypertension of salt-fed adiponectin KO mice was associated with reduced mRNA levels of endothelial NO synthase (eNOS) and prostaglandin I 2 synthase in aorta and low metabolite levels of endothelial NO synthase and prostaglandin I 2 synthase in plasma. Adiponectin therapy lowered the elevated blood pressure and corrected the above mRNA levels to those of the wild type. Our results suggest that hypoadiponectinemia contributes to the development of obesity-related hypertension, at least in part, directly, in addition to its effect via insulin resistance, and that adiponectin therapy can be potentially useful for hypertension in patients with the metabolic syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Adiponectin supplementation reduced BP in salt-fed, adiponectin-knockout mice and in KKAy mice, which develop obesity via ectopic expression of agouti protein117.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [117]
In the citing paper
“The role of adiponectin in cardiometabolic regulation was examined in adiponectin-knockout mice, which had normal BP when maintained on a normal salt intake117. By contrast, when fed a high-salt diet, these mice had greater increases in BP than did control mice, suggesting salt sensitivity of BP.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [117]
In the citing paper
“Antidiabetic (162), anti-inflammatory (348), and antihypertensive (259) effects have all been established to occur in response to adiponectin.”
From Cardiac remodeling in obesity (2008) · cites this paper as [259]
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
Self-citationYamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Self-citationA Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Self-citationThe adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
Cited by
Sorted by citations
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Self-citationCornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction
Elumalai, A., & Jain, S. K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061321 · Cited by 1,206
Pharmacological and Clinical Aspects of Heme Oxygenase
Abraham, N. G., & Kappas, A. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07104 · Cited by 1,115
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
Maury, E., & Brichard, S. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.031 · Cited by 1,026
Obesity, Adipose Tissue and Vascular Dysfunction
Koenen, M., Hill, M. A., Cohen, P., & Sowers, J. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318093 · Cited by 979
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 888
Adiponectin as an anti-inflammatory factor
Ouchi, N., & Walsh, K. X. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.01.026 · Cited by 910
Self-citationAbel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Adipose Tissue-Derived Factors: Impact on Health and Disease
Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 624
Adipokines: A link between obesity and cardiovascular disease
Nakamura, K., Fuster, J. J., & Walsh, K. X. (2013) · Journal of Cardiology · doi:10.1016/j.jjcc.2013.11.006 · Cited by 597
Self-citationMultifaceted Physiological Roles of Adiponectin in Inflammation and Diseases
Choi, H. M., Doss, H. M., & Kim, K. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041219 · Cited by 536
Pathophysiology of obesity and its associated diseases
Jin, X., Qiu, T., Li, L., Yu, R., Chen, X., Li, C., Proud, C. G., & Jiang, T. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.01.012 · Cited by 603
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association
Elijovich, F., Weinberger, M. H., Anderson, C. A. M., Appel, L. J., Bursztyn, M., Cook, N. R., Dart, R. A., Newton-Cheh, C. H., Sacks, F. M., & Laffer, C. L. (2016) · Hypertension · doi:10.1161/hyp.0000000000000047 · Cited by 482
Inflammation – Cause or Consequence of Heart Failure or Both?
Linthout, S. V., & Tschöpe, C. (2017) · Current Heart Failure Reports · doi:10.1007/s11897-017-0337-9 · Cited by 484
Post-translational modifications of adiponectin: mechanisms and functional implications
Wang, Y., Lam, K. S. L., Yau, M.-H., & Xu, A. (2008) · Biochemical Journal · doi:10.1042/bj20071492 · Cited by 417
Cheng, K. K. Y., Lam, K. S. L., Wang, Y., Huang, Y., Carling, D., Wu, D., Wong, C., & Xu, A. (2007) · Diabetes · doi:10.2337/db06-1580 · Cited by 318
Li, M., Kim, D. H., Tsenovoy, P. L., Peterson, S. J., Rezzani, R., Rodella, L. F., Aronow, W. S., Ikehara, S., & Abraham, N. G. (2008) · Diabetes · doi:10.2337/db07-1764 · Cited by 313
Role of adipokines in cardiovascular disease
Mattu, H. S., & Randeva, H. S. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0232 · Cited by 298
Protective vascular and myocardial effects of adiponectin
Goldstein, B. J., Scalia, R. G., & Ma, X. L. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1398 · Cited by 295
APPL1: role in adiponectin signaling and beyond
Deepa, S. S., & Dong, L. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90731.2008 · Cited by 295
Inter-organ cross-talk in metabolic syndrome
Priest, C., & Tontonoz, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0145-5 · Cited by 279
Adiponectin is a novel humoral vasodilator
Fésüs, G., Dubrovska, G., Gorzelniak, K., KLUGE, R., Huang, Y., Luft, F. C., & Gollasch, M. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.025 · Cited by 276
Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue
Saxton, S. N., Clark, B., Withers, S., Eringa, E. C., & Heagerty, A. M. (2019) · Physiological Reviews · doi:10.1152/physrev.00034.2018 · Cited by 290
Mouse models of the metabolic syndrome
Kennedy, A. J., Ellacott, K. L. J., King, V. L., & Hasty, A. H. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003467 · Cited by 265
Castrop, H., Höcherl, K., Kurtz, A., Schweda, F., Todorov, V., & Wagner, C. (2010) · Physiological Reviews · doi:10.1152/physrev.00011.2009 · Cited by 265
Hypoadiponectinemia as a Predictor for the Development of Hypertension
Chow, W.-S., Cheung, B. M. Y., Tso, A. W. K., Xu, A., Wat, N. M. S., Fong, C. H.-Y., Ong, L. H. Y., Tam, S., Tan, K. C. B., Janus, E. D., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086835 · Cited by 262
Adiponectin, Cardiovascular Function, and Hypertension
Wang, Z. V., & Scherer, P. E. (2008) · Hypertension · doi:10.1161/hypertensionaha.107.099424 · Cited by 247
Anti-inflammatory and anti-atherogenic properties of adiponectin
Ohashi, K., Ouchi, N., & Matsuzawa, Y. (2012) · Biochimie · doi:10.1016/j.biochi.2012.06.008 · Cited by 232
Self-citationObesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity
Canale, M. P., di Villahermosa, S. M., Martino, G., Rovella, V., Noce, A., LORENZO, A. D., & Daniele, N. D. (2013) · International Journal of Endocrinology · doi:10.1155/2013/865965 · Cited by 224
Adipocytokines in relation to cardiovascular disease
de Voorde, J. V., Pauwels, B., Boydens, C., & Decaluwé, K. (2013) · Metabolism · doi:10.1016/j.metabol.2013.06.004 · Cited by 215
Adiponectin and Cardiovascular Disease
Shibata, R., Ouchi, N., & Murohara, T. (2009) · Circulation Journal · doi:10.1253/circj.cj-09-0057 · Cited by 214
Self-citationMasuyama, H., & Hiramatsu, Y. (2012) · Endocrinology · doi:10.1210/en.2011-2161 · Cited by 212
Adiponectin protects against the development of systolic dysfunction following myocardial infarction
Shibata, R., Izumiya, Y., Sato, K., Papanicolaou, K. N., Kihara, S., Colucci, W. S., Sam, F., Ouchi, N., & Walsh, K. X. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.03.808 · Cited by 213
Self-citationMirza, M. A. I., Alsiö, J., Hammarstedt, A., Erben, R. G., Michaëlsson, K., Tivesten, Å., Marsell, R., ORWOLL, E. S., Karlsson, M. K., Ljunggren, Ö., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.214619 · Cited by 182
Adipokines, Myokines and Cardiovascular Disease
Walsh, K. X. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0961 · Cited by 178
Self-citationRole of Adipokines in Cardiovascular Disease
Lau, W. B., Ohashi, K., Wang, Y., Ogawa, H., Murohara, T., Ma, X., & Ouchi, N. (2017) · Circulation Journal · doi:10.1253/circj.cj-17-0458 · Cited by 183
Self-citationTakebayashi, K., Suetsugu, M., Wakabayashi, S., Aso, Y., & Inukai, T. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.001 · Cited by 174
The metabolic syndrome and chronic kidney disease
Zhang, X., & Lerman, L. O. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.004 · Cited by 185
Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK–eNOS Pathway
Deng, G., Long, Y., Yu, Y.-R., & Li, M.-R. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.205 · Cited by 165
Cardiac-specific deletion of LKB1 leads to hypertrophy and dysfunction
Ikeda, Y., Sato, K., Pimentel, D. R., Sam, F., Shaw, R. J., Dyck, J. R. B., & Walsh, K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.057273 · Cited by 164
Self-citationThe role of the sympathetic nervous system in obesity-related hypertension
da Silva, A. A., do Carmo, J. M., Dubinion, J. H., & Hall, J. E. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0036-3 · Cited by 156
Peterson, S. J., Drummond, G., Kim, D. H., Li, M., Kruger, A. L., Ikehara, S., & Abraham, N. G. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800046-jlr200 · Cited by 153
Cross-talk between adipose tissue and vasculature: role of adiponectin
Li, F. Y. L., Cheng, K. K. Y., Lam, K. S. L., Vanhoutte, P. M., & Xu, A. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02216.x · Cited by 155
Pathophysiological significance of adiponectin
Nishida, M., Funahashi, T., & Shimomura, I. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0366-7 · Cited by 150
Self-citationAdipokines at the crossroad between obesity and cardiovascular disease
Morel, S., Kwak, B. R., Rohner‐Jeanrenaud, F., Steffens, S., & Molica, F. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-06-0513 · Cited by 149
Regulation of vascular tone by adipocytes
Maenhaut, N., & de Voorde, J. V. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-25 · Cited by 144
Chandrasekar, B., Boylston, W. H., Venkatachalam, K., Webster, N. J. G., Prabhu, S. D., & Valente, A. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804236200 · Cited by 145
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 140
Lynch, F. M., Withers, S., Yao, Z., Werner, M. E., Edwards, G., Weston, A. H., & Heagerty, A. M. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00697.2012 · Cited by 136
Adiponectin and adipocyte fatty acid binding protein in the pathogenesis of cardiovascular disease
Xu, A., & Vanhoutte, P. M. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00765.2011 · Cited by 130
Serum visfatin concentration and endothelial dysfunction in chronic kidney disease
Yılmaz, M. İ., Sağlam, M., Carrero, J. J., Qureshi, A. R., Çağlar, K., Eyileten, T., Sönmez, A., Cakir, E., Yenicesu, M., Lindholm, B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm727 · Cited by 128
Ohashi, K., Ouchi, N., & Matsuzawa, Y. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.216 · Cited by 127
Self-citationEndothelial dysfunction in adiponectin deficiency and its mechanisms involved
Cao, Y., Tao, L., Yuan, Y., Jiao, X., Lau, W. B., Wang, Y., Christopher, T. A., Lopez, B., Chan, L., Goldstein, B., et al. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.014 · Cited by 127
Kurukulasuriya, L. R., Stas, S. N., Lastra, G., Manrique, C. M., & Sowers, J. R. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.004 · Cited by 130
Obesity and Cardiovascular Disease
Obeng-Gyimah, E. K., & Sam, F. (2014) · Humana Press eBooks · doi:10.1007/978-1-62703-770-9_18 · Cited by 126
Kim, D., Burgess, A., Li, M., Tsenovoy, P. L., Addabbo, F., McClung, J. A., Puri, N., & Abraham, N. G. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135285 · Cited by 124
Chapman, M. J., & Sposito, A. C. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.004 · Cited by 123
Adiponectin in Cardiovascular Inflammation and Obesity
Aprahamian, T. R., & Sam, F. (2011) · International Journal of Inflammation · doi:10.4061/2011/376909 · Cited by 124
Dolinsky, V. W., Morton, J. S., Oka, T., Frayne, I. R., Bagdan, M., Lopaschuk, G. D., Rosiers, C. D., Walsh, K. X., Davidge, S. T., & Dyck, J. R. B. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154732 · Cited by 120
Self-citationHusseny, M. W. A. E., Mamdouh, M., Shaban, S., Abushouk, A. I., Zaki, M. M. M., Ahmed, O. M., & Abdel‐Daim, M. M. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8095926 · Cited by 124
Joki, Y., Ohashi, K., Yuasa, D., Shibata, R., Ito, M., Matsuo, K., Kambara, T., Uemura, Y., Hayakawa, S., Hiramatsu‐Ito, M., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.081 · Cited by 114
Self-citationAdiponectin deficiency: a model of pulmonary hypertension associated with pulmonary vascular disease
Summer, R. S., Fiack, C. A., Ikeda, Y., Sato, K., Dwyer, D. F., Ouchi, N., Fine, A., Farber, H. W., & Walsh, K. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90599.2008 · Cited by 113
Self-citationMasuyama, H., Mitsui, T., Eguchi, T., Tamada, S., & Hiramatsu, Y. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00095.2016 · Cited by 114
Aghamohammadzadeh, R., Withers, S., Lynch, F. M., Greenstein, A. S., Malik, R. A., & Heagerty, A. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01479.x · Cited by 107
Xu, A., Wang, H., Hoo, R. L. C., Sweeney, G., Vanhoutte, P. M., Wang, Y., Wu, D., Chu, W., Qin, G., & Lam, K. S. L. (2008) · Endocrinology · doi:10.1210/en.2008-0999 · Cited by 108
Belmadani, S., Palen, D. I., González-Villalobos, R. A., Boulares, H. A., & Matrougui, K. (2008) · Diabetes · doi:10.2337/db07-0739 · Cited by 106
Galán, M., Kassan, M., Choi, S. K., Partyka, M., Trebak, M., Henrion, D., & Matrougui, K. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.192500 · Cited by 105
Qi, G., Jia, L., Li, Y., Li, H., & Du, J. (2014) · Endocrinology · doi:10.1210/en.2013-2011 · Cited by 106
Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond
Lu, J., Huang, K., Chang, L., Huang, Y.-S., Chi, Y., Su, T.-C., Chen, C., & Yang, W. (2008) · Journal of Biomedical Science · doi:10.1007/s11373-008-9261-z · Cited by 104
Masuyama, H., Mitsui, T., Nobumoto, E., & Hiramatsu, Y. (2015) · Endocrinology · doi:10.1210/en.2014-2020 · Cited by 104
Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors
Heiker, J. T., Kosel, D., & Beck‐Sickinger, A. G. (2010) · Biological Chemistry · doi:10.1515/bc.2010.104 · Cited by 105
The Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 104
Adiponectin and Insulin Sensitivity in Primary Aldosteronism
FALLO, F., DELLAMEA, P., SONINO, N., BERTELLO, C., ERMANI, M., VETTOR, R., VEGLIO, F., & MULATERO, P. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2007.03.012 · Cited by 101
Eosinophils are key regulators of perivascular adipose tissue and vascular functionality
Withers, S., Forman, R. A., Meza‐Perez, S., Sorobetea, D., Sitnik, K., Hopwood, T. W., Lawrence, C. B., Agace, W. W., Else, K. J., Heagerty, A. M., et al. (2017) · Scientific Reports · doi:10.1038/srep44571 · Cited by 101
Zha, D., Wu, X., & Gao, P. H. (2017) · Endocrinology · doi:10.1210/en.2016-1765 · Cited by 102
Chow, W. S., Tso, A. W. K., Xu, A., Yuen, M. M. A., Fong, C. H. Y., Lam, T. H., Lo, S. V., Tse, H., Woo, Y. C., Yeung, C. Y., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.112.004176 · Cited by 101
Adipokines and blood pressure control
Yiannikouris, F. B., Gupte, M., Putnam, K., & Cassis, L. A. (2010) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e3283366cd0 · Cited by 98
Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats.
Tanida, M., Shen, J., Horii, Y., Matsuda, M., Kihara, S., Funahashi, T., Shimomura, I., Sawai, H., Fukuda, Y., Matsuzawa, Y., et al. (2007) · PubMed · Cited by 95
Self-citationL’Abbate, A., Neglia, D., Vecoli, C., Novelli, M., Ottaviano, V., Baldi, S., Barsacchi, R., Paolicchi, A., Masiello, P., Drummond, G. S., et al. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2007 · Cited by 95
Vaidya, A., Williams, J. S., & Forman, J. P. (2011) · Obesity · doi:10.1038/oby.2011.210 · Cited by 95
Declèves, A., & Sharma, K. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000087 · Cited by 96
Adipocytokines, cardiovascular pathophysiology and myocardial protection
Smith, C., & Yellon, D. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.003 · Cited by 96
Teoh, H., Quan, A., Bang, K. W. A., Wang, G., Lovren, F., Vu, V. P., Haitsma, J. J., Szmitko, P. E., Al-Omran, M. A., Wang, C., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90384.2008 · Cited by 91
Kondo, K., Shibata, R., Unno, K., Shimano, M., Ishii, M., Kito, T., Shintani, S., Walsh, K. X., Ouchi, N., & Murohara, T. (2010) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.109.872044 · Cited by 89
Self-citationAdiponectin Deficiency, Diastolic Dysfunction, and Diastolic Heart Failure
Sam, F., Duhaney, T.-A. S., Sato, K., Wilson, R. M., Ohashi, K., Sono-Romanelli, S., Higuchi, A., Silva, D. S. D., Qin, F., Walsh, K., et al. (2009) · Endocrinology · doi:10.1210/en.2009-0806 · Cited by 90
Self-citationSharabi, Y., Oron‐Herman, M., Kamari, Y., Avni, I., Peleg, E., Shabtay, Z., Grossman, E., & Shamiss, A. (2007) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.08.002 · Cited by 89
Oral administration of a zinc complex improves type 2 diabetes and metabolic syndromes
Adachi, Y., Yoshida, J., Kodera, Y., Kiss, T., Jakusch, T., Enyedy, É. A., Yoshikawa, Y., & Sakurai, H. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.014 · Cited by 89
Adiponectin Ameliorates Doxorubicin-induced Cardiotoxicity through Akt Protein-dependent Mechanism
Maruyama, S., Shibata, R., Ohashi, K., Ohashi, T., Daida, H., Walsh, K. X., Murohara, T., & Ouchi, N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.245985 · Cited by 85
Self-citationMechanisms of hypertension in the cardiometabolic syndrome
Redón, J., Cífková, R., Laurent, S., Nilsson, P. M., Narkiewicz, K., Erdine, S. E., & Mancia, G. (2009) · Journal of Hypertension · doi:10.1097/hjh.0b013e32831e13e5 · Cited by 86
Additive Effects of Maternal High Fat Diet during Lactation on Mouse Offspring
Masuyama, H., & Hiramatsu, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092805 · Cited by 85
Su, J., Lucchesi, P. A., González-Villalobos, R. A., Palen, D. I., Rezk, B. M., Suzuki, Y., Boulares, H. A., & Matrougui, K. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.167205 · Cited by 85
Ohashi, K., Ouchi, N., Sato, K., Higuchi, A., Ishikawa, T., Herschman, H. R., Kihara, S., & Walsh, K. X. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00126-09 · Cited by 83
Self-citationPotenza, M. A., Sgarra, L., Nacci, C., Leo, V., Salvia, M. A. D., & Montagnani, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210654 · Cited by 81
Ding, M., Xie, Y., Wagner, R. J., Yu, J. H., Carrao, A. C. R., Kohn, L. L., Guzman, A. K., Powell, R. J., Hwa, J., Rzucidlo, E. M., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.216804 · Cited by 82
Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
Lei, X., Qiu, S., Yang, G., & Wu, Q. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.018 · Cited by 91
Adiponectin Synthesis, Secretion and Extravasation from Circulation to Interstitial Space
Rosa, S. C. D. S., Liu, M., & Sweeney, G. (2021) · Physiology · doi:10.1152/physiol.00031.2020 · Cited by 80
Abu‐Farha, M., Behbehani, K., & Elkum, N. B. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-76 · Cited by 78
Hirata, M., Ishigami, M., Matsushita, Y., Ito, T., Hattori, H., Hibi, H., Goto, H., Ueda, M., & Yamamoto, A. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0353 · Cited by 78
Metadata
- Authors
- Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N., Maeda, K., Shibata, R., Walsh, K., Funahashi, T., & Shimomura, I.
- Affiliations
- Boston University (US)
- ORCID
- Venue
- Hypertension
- Published
- 2006-06
- Volume
- 47
- Issue
- 6
- Pages
- 1108-1116
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2166751358
- Cited by
- 400
- References
- 36
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 8 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 61 · 2019: 13 · 2018: 6 · 2017: 14 · 2016: 11 · 2015: 12 · 2014: 25 · 2013: 22 · 2012: 30
- FWCI
- 24.90
- Type
- journal article
- Language
- en
- Update notices
- correction (2006-12-26)
- Open access
- closed
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- adiponectin, obesity-related hypertension, hypoadiponectinemia, KK-Ay mice, adiponectin knockout mice, high-salt diet, endothelial nitric oxide synthase, PTGIS, nitric oxide, insulin resistance, metabolic syndrome, blood pressure regulation
- MeSH terms
- Adenoviridae, Animals, Aorta, Blood Pressure, Cytochrome P-450 Enzyme System, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Enzyme Inhibitors, Genetic Vectors, Hypertension, Insulin Resistance, Male, Mice, Inbred Strains, Obesity, RNA, Messenger, Sodium Chloride, Dietary, Gene Transfer Techniques, Mice, Knockout, NG-Nitroarginine Methyl Ester, Intramolecular Oxidoreductases, Mice, Adiponectin, Nitric Oxide Synthase Type III
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review